ZIOPHARM ONCOLOGY INC Development Agreements

12 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment #1 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of August...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Fourth Amendment to the Cooperative Research and Development Agreement, dated June 24, 2022, by and between the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Third Amendment to the Cooperative Research and Development Agreement, dated March 15, 2022, by and among the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
2019 Research and Development Agreement, dated October 22, 2019, by and between the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2020
Fifth Amendment to Research and Development Agreement, dated October 22, 2019 by and among the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2020
Fourth Amendment to Research and Development Agreement, dated September 19, 2019 by and between the Registrant, The University of Texas MD Anderson Cancer Center and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #2 to the Cooperative Research and Development Agreement, dated February 1, 2019, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #1 to the Cooperative Research and Development Agreement, dated March 23, 2018, by and among the National Cancer Institute, Ziopharm Oncology, Inc., Intrexon Corporation...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Cooperative Research and Development Agreement, dated January 9, 2017, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Intrexon Corporation
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DC
2019
Amendment #3 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #2 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
RESEARCH AND DEVELOPMENT AGREEMENT
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2015